University of Missouri researchers have discovered two potential biomarkers of glaucoma – agmatine and thiamine ...

2025 Financial Guidance Sight Sciences raises its revenue guidance expectations for full year 2025 to $76.0 million to $78.0 million, representing a 2% to 5% decline compared to full year 2024 revenue ...

Researchers at SIU’s School of Biological Sciences are leading the effort to create a cheaper, more environmentally-friendly treatment for myopia, or nearsightedness.

Neurelis, Inc., today announced it will present at the Alliance to Cure Cavernous Malformation (CCM) 21st International CCM Scientific & Clinical Meeting to be held November 6-7, 2025, in Atlanta, ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial biotechnology company, today announced that Seth Lederman, M.D., Tonix’s Chief Executive ...

When Lambert started losing his vision and slowing down a few steps, it became clear that he needed to be relocated to a ...

What are the signs that show I need cataract surgery? “There are several key signs that someone may need cataract surgery,” ...

Lack of sleep isn't the only thing to blame for those dark circles under your eyes. Four doctors share why they happen, and ...

In this inaugural episode of the Ophthalmology Times ® “Beyond The Walls” podcast, host Deborah Ristvedt, DO, of Vance ...

With nearly 90 million Indians living with diabetes, the country is facing a rising crisis of avoidable blindness. Diabetes ...

Phase 3 AQUILA study showed DARZALEX FASPRO® significantly reduced the risk of progression to active multiple myeloma or death by 51 percent compared to ...

New leadership appointments strengthen Sight Sciences’ commitment to advancing our interventional dry eye initiatives and ...